Torrent Pharmaceuticals Limited has informed the Exchange about issue of Securities

Fund Raising View source PDF Explain this filing

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹3619.70

prior close

₹3616.60

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.7%-1.4% vs market

Pharmaceuticals peers, median of 154sector-0.8%-1.3% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty 100 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.1

15m

-0.3

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1-0.7-1.4-0.8-1.3

Next day

-0.9-1.7+0.9-3.1+2.3

-0.7-1.6+1.0-3.2+2.5

-0.7-1.7+1.0-3.2+2.5

-1.5-0.9-0.6-2.4+0.9

-2.9-0.6-2.3-2.1-0.8

-2.2+0.1-2.4-2.9+0.7

15d

-1.3+2.3-3.6-3.5+2.2

-0.9+3.2-4.1-3.4+2.5

+3.3+2.6+0.7-7.0+10.3

+5.9+3.3+2.6-5.8+11.7

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Torrent Pharmaceuticals has issued Commercial Papers (CPs) amounting to ₹200 Crores on September 24, 2025. The CPs carry a short tenure of 90 days, maturing on December 23, 2025, with a coupon rate of 5.93% per annum paid upfront. The instrument is unsecured and is proposed to be listed on the NSE. Principal repayment is scheduled at maturity. This is a routine short-term money market borrowing, typically used to meet working capital needs.

Likely market impact

This is a small, short-term debt raise at a competitive interest rate, unlikely to materially affect the stock price or shareholders. It signals routine treasury management rather than any significant capital event.